Alfuzosin Hydrochloride

Product NDC
0378-5005
11-digit product format
003785005
Labeler code
0378
Product ID
0378-5005_0cb40738-5a0d-456f-b8cb-3aa25159e520
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
alfuzosin
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
Mylan Pharmaceuticals Inc.
Application
ANDA079014
Marketing category
ANDA
Marketing start
2011-08-09
Marketing end
2019-10-31
Substance
ALFUZOSIN HYDROCHLORIDE
Active strength
10 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
8b671e1a-6f8a-5de4-69a7-83132df7952dProduct name320201015

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0378-5005-05EA - Each0378-5005290d904b-6941-4db0-9a7d-93fde8a9823812012-07-24
0378-5005-77EA - Each0378-5005610f8710-99d1-44d1-bb49-c36576ea851012012-07-24

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
861132alfuzosin HCl 10 MG 24HR Extended Release Oral TabletPSNbe2c5e2e-6435-4d0f-bf5c-79dbcab99ebb1
86113224 HR alfuzosin hydrochloride 10 MG Extended Release Oral TabletSCDbe2c5e2e-6435-4d0f-bf5c-79dbcab99ebb1
861132alfuzosin hydrochloride 10 MG 24 HR Extended Release Oral TabletSYbe2c5e2e-6435-4d0f-bf5c-79dbcab99ebb1